Home > Press > Third-Order Nanotechnolgies, Inc. Announces that Its Common Stock Now Trades on the Over-the-Counter Bulletin Board
Abstract:
Third-Order Nanotechnologies, Inc. (OTCBB:TDON) (http://www.third-order.com) announced that effective today its common stock now trades on the over-the-counter bulletin board. Its trading symbol remains (TDON). Third-order is a technology company focused on the development of electro-optic polymer materials for applications in high-speed fiber-optic telecommunications and optical computing.
Hal Bennett, Chief Executive Officer of Third-Order, commented, "As Third-Order moves forward with the development and commercialization of our materials, we believe it is necessary to take measures to ensure that information concerning our company and its common stock is available to those interested in our potential. Our listing on the OTC Bulletin Board is likewise part of our strategy to increase the liquidity of our common stock and thus investor confidence in our company. Being listed on the OTC Bulletin Board, therefore, is an important milestone in the development of our company."
Third-Order previously registered its common stock under the provisions of Section 12(g) of the Securities Exchange Act of 1934 and is required to comply with periodic reporting, proxy solicitations and certain other requirements of the Securities Exchange Act. These filings can be viewed in their entirety on the SEC's website at www.sec.gov.
####
About Third-Order Nanotechnologies, Inc.
Third-Order Nanotechnologies is a development stage company, moving toward prototype demonstration and commercialization of its high-activity, high-stability organic polymers for applications in electro-optic device markets. Electro-optical devices convert data from electric signals into optical signals for use in high-speed fiber-optic telecommunications systems and optical computers. Third-Order Nanotechnologies is a portfolio company of Universal Capital Management, Inc. (OTCBB:UCMT). Please visit the Company’s website, www.third-order.com, for more information.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.
For more information, please click here
Contacts:
Third-Order Nanotechnologies
Hal Bennett
707-256-3656
or
The Investor Relations Group
Erika Moran/Tom Caden/Salima Rasul
Public Relations
Steven Melfi/Lynn Granito
212-825-3210
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||